CTRI/2019/04/018599进行中（未招募）未知
Effects of Oral Hypoglycemic Agents on Bone Turnover Markers & Fracture Risk in Patients with Type 2 Diabetes Mellitus-A Prospective Study
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with type 2 diabetes mellitus, attending the out-patient and in-patient services of Medicine department prescribed with Metformin or Metformin in combination with DPP-4 inhibitor-Teneligliptin, SGLT2 inhibitor-Empagliflozin who are willing to participate in the study will be enrolled from baseline to 3 months followup.
排除标准
- •Patients with chronic alcoholism and smoking/tobacco use
- •Patients with primary and secondary causes of bone loss
- •Patients who are on medications that may affect bone metabolism
- •Patients who are not willing to participate in the study, mentally challenged and unconscious patients
研究者
相似试验
尚未招募
4 期
Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 DiabetesDiabetes Type 2OsteoporosisNCT06439758King Saud University111
招募中
不适用
Study of effect of oral anti-diabetic medication on cognitive function in young and middle-aged type 2 diabetes mellitus patientsCTRI/2020/02/023645Dr Vangaveti Sneha
进行中（未招募）
1 期
How improved sensitivity to insulin affects bone health in persons with type 2 diabetesType 2 diabetes mellitus Diabetic bone diseaseMedDRA version: 21.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2019-003771-19-DKAarhus Universitetshospital104
已完成
不适用
The effects on bone metabolism in patients using hydroxychloroquineosteoporosisNL-OMON42271Erasmus MC, Universitair Medisch Centrum Rotterdam81
已完成
4 期
Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic VariabilityOsteopeniaType 2 Diabetes MellitusOsteoporosisMenopauseNCT01679899Centro de Diabetes Curitiba Ltda56